Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Coleman Smith

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Clinical Transplantation|January 12, 2018
Direct-acting antiviral regimens are safe and effective in the treatment of hepatitis C in simultaneous liver-kidney transplant recipientsAnupama U Nookala, James Crismale, Thomas Schiano, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 23, 2021
Risk factors for bleeding hepatocellular adenoma in a United States cohortChelsea McDermott, Marco Ertreo, Reena Jha, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|September 27, 2017
Sharp Morphological Transitions from Nanoscale Mixed-Anchoring Patterns in Confined Nematic Liquid CrystalsJulio C Armas-Pérez, Xiao Li, José A Martínez-González, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 24, 2019
Long-term survival in visceral transplant recipients in the new era: A single-center experienceAhmed M Elsabbagh, Jason Hawksworth, Khalid M Khan, et al.
Hepatology (Baltimore, Md.)|May 30, 2003
A multicenter study of recombinant human interleukin 12 for the treatment of chronic hepatitis C virus infection in patients nonresponsive to previous therapyPaul J Pockros, Keyvr Patel, Christopher O'Brien, et al.
Digestive Diseases and Sciences|April 5, 2007
Antiviral response of HCV genotype 1 to consensus interferon and ribavirin versus pegylated interferon and ribavirinMaria H Sjogren, Robert Sjogren, Michael F Lyons, et al.
Annals of Gastroenterological Surgery|March 31, 2023
Bridging and downstaging with TACE in early and intermediate stage hepatocellular carcinoma: Predictors of receiving a liver transplantChao Yin, Samantha Armstrong, Richard Shin, et al.
Journal of Hepatology|March 20, 2004
The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis CTarek Hassanein, Graham Cooksley, Mark Sulkowski, et al.
Clinical Transplantation|February 26, 2018
Impact of early reoperation on graft survival after liver transplantation: Univariate and multivariate analysisAhmed M Elsabbagh, Raffaele Girlanda, Jason Hawksworth, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 23, 2023
Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET studyWesam Aleyadeh, Elizabeth C Verna, Hany Elbeshbeshy, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Clinical Transplantation|January 12, 2018
Direct-acting antiviral regimens are safe and effective in the treatment of hepatitis C in simultaneous liver-kidney transplant recipientsAnupama U Nookala, James Crismale, Thomas Schiano, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 23, 2021
Risk factors for bleeding hepatocellular adenoma in a United States cohortChelsea McDermott, Marco Ertreo, Reena Jha, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|September 27, 2017
Sharp Morphological Transitions from Nanoscale Mixed-Anchoring Patterns in Confined Nematic Liquid CrystalsJulio C Armas-Pérez, Xiao Li, José A Martínez-González, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 24, 2019
Long-term survival in visceral transplant recipients in the new era: A single-center experienceAhmed M Elsabbagh, Jason Hawksworth, Khalid M Khan, et al.
Hepatology (Baltimore, Md.)|May 30, 2003
A multicenter study of recombinant human interleukin 12 for the treatment of chronic hepatitis C virus infection in patients nonresponsive to previous therapyPaul J Pockros, Keyvr Patel, Christopher O'Brien, et al.
Digestive Diseases and Sciences|April 5, 2007
Antiviral response of HCV genotype 1 to consensus interferon and ribavirin versus pegylated interferon and ribavirinMaria H Sjogren, Robert Sjogren, Michael F Lyons, et al.
Annals of Gastroenterological Surgery|March 31, 2023
Bridging and downstaging with TACE in early and intermediate stage hepatocellular carcinoma: Predictors of receiving a liver transplantChao Yin, Samantha Armstrong, Richard Shin, et al.
Journal of Hepatology|March 20, 2004
The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis CTarek Hassanein, Graham Cooksley, Mark Sulkowski, et al.
Clinical Transplantation|February 26, 2018
Impact of early reoperation on graft survival after liver transplantation: Univariate and multivariate analysisAhmed M Elsabbagh, Raffaele Girlanda, Jason Hawksworth, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 23, 2023
Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET studyWesam Aleyadeh, Elizabeth C Verna, Hany Elbeshbeshy, et al.
Pageof 3